Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate vs Cyclophosphamide for SNV Remission Maintenance
NCT00751517Phase 2Unknown
- Sponsor
- University of Parma
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of methotrexate in granulomatosis with polyangiitis (GPA), eosinophilic granulomatosis with polyangiitis (EGPA), microscopic polyangiitis (MPA) and 1 more (2 arms), sponsored by University of Parma. Primary endpoint: Time from remission to relapse. Status: unknown.
02
Drugs
methotrexate
03
Conditions
granulomatosis with polyangiitis (GPA)eosinophilic granulomatosis with polyangiitis (EGPA)microscopic polyangiitis (MPA)polyarteritis nodosa (PAN)
Beyond the preview
Go deeper on NCT00751517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00751517.